Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC)

被引:5
|
作者
Groppe, Markus [1 ]
Bindra, Mandeep Singh [1 ]
机构
[1] Buckinghamshire Healthcare NHS Trust, Retina Unit, Stoke Mandeville & Amersham Hosp, Aylesbury HP21 8AL, Bucks, England
来源
CLINICAL OPHTHALMOLOGY | 2021年 / 15卷
关键词
age-related macular degeneration; COVID-19; social distancing; SDOC; RANIBIZUMAB TREAT; EXTEND REGIMEN; INJECTIONS; OUTCOMES;
D O I
10.2147/OPTH.S269596
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: COVID-19 has had a major impact on health-care provision. Social distancing will impact the organization of outpatient clinics (OCs) and require general restructuring of health care. Methods: Our retinal team participated in a structured fact-finding session to implement social distancing of patients and staff in wet age-related macular degeneration (wAMD) clinics. Clinic flow and performance were continually reviewed and improved. A retrospective audit of all wAMD follow-up appointments was conducted for 4 weeks from the start of the UK lockdown. A search for clinical guidance regarding retinal services was performed on the homepages of international professional bodies. The guidelines were compared to the implemented changes in our wAMD social distancing OCs (SDOCs) and potential risk examined. Results: The changes in clinic setup to achieve SDOCs are described. The average total time spent in the clinic area by each patient has reduced by 27%. The audit concluded that 65% of patients needed a treatment interval of 4-7 weeks after their appointment, 17% at either 8 or 9 weeks, and 18% at 10 weeks or beyond. The UK, Australian-New Zealand, US, and German professional ophthalmology bodies have published divergent guidelines, but all recommended a continuation of anti-VEGF injections. Conclusion: Health-care provision will change and hospitals and outpatient facilities will have to adapt to the COVID-19 epidemic. We describe a clinic setup (SDOCs) that minimizes risk to patients and staff, while maintaining the ability to treat each patient and their disease individually.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 50 条
  • [1] Teleophthalmology for age-related macular degeneration during the COVID-19 pandemic and beyond
    Mintz, Joel
    Labiste, Chase
    DiCaro, Michael, V
    McElroy, Evan
    Alizadeh, Reza
    Xu, Kunyong
    JOURNAL OF TELEMEDICINE AND TELECARE, 2022, 28 (09) : 670 - 679
  • [2] Management of Neovascular Age-Related Macular Degeneration during the COVID-19 Pandemic
    Corradetti, Giulia
    Corvi, Federico
    Tieu Vy Nguyen
    Sadda, SriniVas R.
    OPHTHALMOLOGY RETINA, 2020, 4 (08): : 757 - 759
  • [3] Telehealth improves follow-up and monitoring of age-related macular degeneration during the COVID-19 pandemic
    Huther, Alexander
    Roh, Shiyoung
    Ramsey, David J.
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (12) : 5031 - 5043
  • [4] Telehealth improves follow-up and monitoring of age-related macular degeneration during the COVID-19 pandemic
    Alexander Huther
    Shiyoung Roh
    David J. Ramsey
    International Ophthalmology, 2023, 43 : 5031 - 5043
  • [5] Addressing COVID-19 fear to improve clinic attendance for patients with wet age-related macular degeneration
    Fung, Timothy H. M.
    Kuet, Mong-Loon
    Patel, Moneesh K.
    Puri, Pankaj
    ACTA OPHTHALMOLOGICA, 2021, 99 (02) : E285 - E285
  • [6] Exercise and Fitness in the Age of Social Distancing During the COVID-19 Pandemic
    Nyenhuis, Sharmilee M.
    Greiwe, Justin
    Zeiger, Joanna S.
    Nanda, Anil
    Cooke, Andrew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (07): : 2152 - 2155
  • [7] Treating neovascular age-related macular degeneration in the era of COVID-19
    Fares Antaki
    Ali Dirani
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1567 - 1569
  • [8] Treating neovascular age-related macular degeneration in the era of COVID-19
    Antaki, Fares
    Dirani, Ali
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (07) : 1567 - 1569
  • [9] The Effect of Treatment Delay on Exudative Age-Related Macular Degeneration Patients Due to the COVID-19 Pandemic
    Ghosh, Arko
    Blahnik, Tyler
    Fleischman, David
    Zhang, Alice
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [10] Impact of COVID-19 restrictions on the treatment of neovascular age-related macular degeneration
    Nordsten, Cecilie Bagi
    Rasmussen, Bjarke Kare
    Li, Xiaoqiang
    Thomsen, Alexander Kai
    Sorensen, Torben Lykke
    ACTA OPHTHALMOLOGICA, 2024, 102 (03) : e404 - e405